imageSlide

Connect with us

60px
medium
Dark image with red solutions in five types of scientific glassware
share icon

Our team is ready to connect with you and learn more about your science.

60px
spacer
small
spacer
large
spacer
large

Corporate business
development

48px

Jake Van Naarden

28px
Executive Vice President; President, Lilly Oncology and Head of Corporate Business Development
14px
spacer
large
spacer
large
spacer
large
spacer
large
Search & evaluation
standardTitle
1Column

Diabetes, Obesity, and Complications
Benjamin Yaden, PhD

Digital Health
David Kusch
Jim Koers (Clinical Capabilities)

Genetic Medicines
RNA Team
Amanda Placone, PhD (Gene Therapy and Editing)

Immunology
David Shrom, PhD

Molecule Innovation (Biologics)
Andrew Korytko, PhD

Molecule Innovation (Discovery Chemistry)
Guoxin Zhu, PhD
Jim Koers (Novel Drug Development Methods)

Neuroscience
Jenny Laird, PhD (Neurology and Pain)
Hallee Foster (Psychiatry)

Oncology
Tyler Robinson

Search & Evaluation

16px
standardTitle
1Column

Devices & Delivery
Kimberly Kam

Diabetes, Obesity, and Complications
Benjamin Yaden, PhD

Digital Health
David Kusch

Genetic Medicines
Amanda Placone, PhD

Immunology
David Shrom, PhD

Molecule Innovation (Biologics)
Andrew Korytko, PhD

Molecule Innovation (Discovery Chemistry)
Guoxin Zhu, PhD

Neuroscience
Jenny Laird, PhD (Neurology and Pain)
Hallee Foster (Psychiatry)

Oncology
Tyler Robinson

Transactions

16px
standardTitle
1Column

Head of Corporate Business Development Transactions and M&A
Jake Shuman

Diabetes, Obesity, and Complications
Jeff Andrews

Genetic Medicines
Michael Johnson

Immunology
Jeremy Fitch

International and Manufacturing
James A. (Andy) McGee

Neuroscience
Tim Dolan

Oncology
David Kutoloski

Alliance & innovation management

16px
standardTitle
1Column

Head of Alliance and Innovation Management
Wanda Rutledge-Gordon, PhD

Acquisitions
Kristi Huntington

Diabetes, Obesity, and Complications
Jamie McKenzie

Genetic Medicines, Neuroscience, Discovery/Chemistry/Research/Technology
Linda Kehn

Immunology, Oncology
Brent Harvey

International, Biotherapeutic Discovery Research
Lisa Keough

large

Lilly Catalyze360

48px

Nisha Nanda, PhD

28px
Group VP, Head of Lilly Catalyze360
14px
spacer
large
spacer
large
spacer
large
Lilly Ventures
standardTitle
1Column

Lilly Ventures Global Head
Brad Robling

Lilly Venture Science Global Head
Jim MacKrell, PhD

Lilly Venture Science Europe Hub
Laura Lane, PhD

Lilly Venture Science West Coast Hub
Tim Luker, PhD

Lilly Venture Science Asia Hub
Gurkee Singh, PhD

Lilly Ventures

16px
standardTitle
1Column

Lilly Ventures Global Head
Brad Robling

Lilly Venture Science Global Head
Jim MacKrell, PhD

Lilly Venture Science Europe Hub
Laura Lane, PhD

Lilly Venture Science West Coast Hub
Tim Luker, PhD

Lilly Venture Science Asia Hub
Gurkee Singh, PhD

Lilly Gateway Labs

16px
standardTitle
1Column

Contact Us
gatewaylabs@lilly.com

Lilly Gateway Labs Global Head
Julie Gilmore, PhD

Lilly Gateway Labs Boston Hub
Vanessa Barth, PhD

Lilly Gateway Labs San Francisco Hub
Nina Kosaric, PhD

Lilly Gateway Labs San Diego Hub
Kathleen Lin, PhD

Lilly Gateway Labs China Hub
Yang Liu, PhD

Lilly Gateway Labs Europe Hub
Verena Stocker

Lilly ExploR&D

16px
standardTitle
1Column

Lilly ExploR&D Head
Tom Hopkins, MD, PhD

Lilly ExploR&D CMO
Florencia Segal, MD

Lilly ExploR&D Head of Clinical Program Management
Daniel Mudra, PhD

Lilly ExploR&D External Partnering
Everett Perkins

16px

Lilly TuneLab

16px
standardTitle
1Column

Lilly TuneLab and Catalyze 360 AI/ML Global Head
Aliza Apple, PhD

Lilly TuneLab, AI/ML and Platform Strategy and Partnerships
Gregg Spivey

Lilly TuneLab, East Coast & Europe User Hub
Jonathan Gilbert, PhD

Lilly TuneLab, West Coast & APAC User Hub
Vanessa Braunstein

spacer
spacer
spacer
large
spacer
large
Collection of Lilly heritage insulins
Corporate business development
We seek the most powerful science for strategic partnerships, licensing and potential acquisitions in our core therapeutic areas. Through Search & Evaluation, Transactions and Alliance & Innovation Management, we operate on the frontiers of medicine development.
Learn more about who we are
link
/science/partners/corporate-business-development
Collection of Lilly heritage insulins
Corporate business development
32px
Built to engage biotechs at the earliest stages and agnostic of therapeutic area, we offer a global investment arm with Lilly Ventures; lab facilities and scientific engagement through Lilly Gateway Labs; and R&D solutions via Lilly ExploR&D.
16px
Learn more about who we are
link
/science/partners/corporate-business-development
Three pipettes with a droplet of solution from one
Lilly Catalyze360
32px
Built to engage biotechs at the earliest stages and agnostic of therapeutic area, we offer a global investment arm with Lilly Ventures; lab facilities and scientific engagement through Lilly Gateway Labs; and R&D solutions via Lilly ExploR&D.
16px
Learn more about our solutions
link
/science/partners/catalyze-360
spacer
large
spacer
large